Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 602911
                    [Title] => Roche's Bevacizumab Offers Hope to Brain Cancer Patients
                    [Summary] => 
After over a decade that saw no new effective therapy developed for the most common and aggressive form of brain cancer, Roche’s bevacizumab now offers hope to patients with recurrent or progressive glioblastoma (GBM).
                    [DatePublished] => 2010-08-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Freeman Cebu Lifestyle
                    [SectionUrl] => cebu-lifestyle
                    [URL] => 
                )

        )

)

GBM

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 602911
                    [Title] => Roche's Bevacizumab Offers Hope to Brain Cancer Patients
                    [Summary] => 
After over a decade that saw no new effective therapy developed for the most common and aggressive form of brain cancer, Roche’s bevacizumab now offers hope to patients with recurrent or progressive glioblastoma (GBM).
                    [DatePublished] => 2010-08-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Freeman Cebu Lifestyle
                    [SectionUrl] => cebu-lifestyle
                    [URL] => 
                )

        )

)

abtest

Roche's Bevacizumab Offers Hope to Brain Cancer Patients

August 16, 2010 - 12:00am

After over a decade that saw no new effective therapy developed for the most common and aggressive form of brain cancer, Roche’s bevacizumab now offers hope to patients with recurrent or progressive glioblastoma...

Freeman Cebu Lifestyle